About Yesse Technologies
Yesse Technologies is a company based in New York (United States) founded in 2016. Yesse Technologies has raised $3.3 million across 4 funding rounds from investors including The Michael J. Fox Foundation, imec.xpand and America’s Seed Fund. Yesse Technologies operates in a competitive market with competitors including Scentian Bio:, Cardea Bio, Hememics Biotechnologies, Nix and Aligned Bio, among others.
- Headquarter New York, United States
-
Sectors
TechnologyHealthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3.3 M (USD)
in 4 rounds
-
Latest Funding Round
$670 K (USD), Grant
Jan 19, 2021
-
Investors
The Michael J. Fox Foundation
& 2 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Yesse Technologies
Yesse Technologies has successfully raised a total of $3.3M across 4 strategic funding rounds. The most recent funding activity was a Grant round of $670 thousand completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Yesse Technologies
Yesse Technologies has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include The Michael J. Fox Foundation, imec.xpand and America’s Seed Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund backed by the US Government
|
Locked | Locked | Locked | |
|
Venture capital is invested in early-stage semiconductor and nanotechnology firms.
|
Locked | Locked | Locked | |
|
Research for Parkinson's disease is funded by the foundation.
|
Locked | Locked | Locked |
Investor details for Yesse Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Yesse Technologies
Investment portfolio details for Yesse Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Yesse Technologies
Detailed financials for Yesse Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Yesse Technologies Comparisons
Peer comparison for Yesse Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Yesse Technologies
Yesse Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scentian Bio:, Cardea Bio, Hememics Biotechnologies, Nix and Aligned Bio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of biosensor devices based on insect odorant receptors for commercial use in the medical & food industries
|
|
| Locked | Locked | Locked |
Digital graphene biosensors are developed using machine learning.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Sweat-based biosensors are provided for body hydration monitoring.
|
|
| Locked | Locked | Locked |
Nanowire-based sensors and alignment technologies are provided for molecular detection.
|
|
| Locked | Locked | Locked |
Developer of biosensors to detect viral proteins, toxins, antibodies, and other molecules
|
Detailed competitors of Yesse Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Yesse Technologies
Complete news archive for Yesse Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yesse Technologies
Yesse Technologies was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Yesse Technologies is headquartered in New York, United States. It is registered at New York, New York, United States.
Yesse Technologies is a funded company, having raised a total of $3.3M across 4 funding rounds to date.
Yesse Technologies was founded in 2016 in New York, United States, within the biotechnology sector. A nanochip genetic platform called ORion21 has been engineered, featuring specific chemical detectors and odorant receptors. This system enables ex vivo measurement of odor activation through standard biochemical assays. Operations focus on advancing olfactory sensing technologies for research and applications.
Yesse Technologies has 3 investors. Key investors include The Michael J. Fox Foundation, imec.xpand, and America’s Seed Fund.